Beth Beilfuss

829 citations
10 papers · 585 indexed · h-index 10
Topics
Cutaneous Melanoma Detection and Management (7 papers)Immunotherapy and Immune Responses (3 papers)Cancer Genomics and Diagnostics (3 papers)
Partner nations
United StatesFrance

In The Last Decade

Beth Beilfuss

10 papers receiving 578 citations

Peers

Beth Beilfuss
Comparison fields: 5 of 55
  • Oncology 380
  • Molecular Biology 267
  • Cancer Research 141
  • Immunology 125
  • Surgery 55
Replace Dale H. Conaway with:
Dale H. Conaway United States
Alessandra Ratto Italy
Margaret Duggan‐Keen United Kingdom
Catherine Ibisch France
Tihui Fu United States
Daniel J. Tanner United States
Linda Hanlon United Kingdom
W. Harel United States
Reinhard Kulke Germany
Françoise Quintin‐Colonna France
Beth Beilfuss relative to Dale H. Conaway United States Dale H. Conaway's profile →
Citations per field
00.5×6.7×
Dale H. Conaway · 1×
Citations per year

Countries citing papers authored by Beth Beilfuss

Since Specialization
Citations

This map shows the geographic impact of Beth Beilfuss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth Beilfuss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth Beilfuss more than expected).

Fields of papers citing papers by Beth Beilfuss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth Beilfuss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth Beilfuss. The network helps show where Beth Beilfuss may publish in the future.

Co-authorship network of co-authors of Beth Beilfuss

This figure shows the co-authorship network connecting the top 25 collaborators of Beth Beilfuss. A scholar is included among the top collaborators of Beth Beilfuss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth Beilfuss. Beth Beilfuss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 70
2 159
3 17
4 39
5 79
6 23
7 54
8 28
9 56
10 60

About Beth Beilfuss

Beth Beilfuss is a scholar working on Oncology, Virology and Cancer Research, having authored 10 papers that have together received 585 indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (7 papers), Immunotherapy and Immune Responses (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Oncology (380 citations), Virology (48 citations) and Cancer Research (141 citations). Beth Beilfuss has collaborated with scholars based in United States and France. Frequent co-authors include Pedram Gerami, Joan Guitart, Gijs A. van Seventer, Bryan Gammon, Pedram Pouryazdanparast, Bradford L. McRae, Klaus J. Busam, Zahra Haghighat, Beth Blondin and Susan Jewell. Their work appears in journals such as The Journal of Immunology, PLoS Pathogens and The American Journal of Surgical Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026